We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About GenixCure Stock

Invest in or calculate the value of your shares in GenixCure or other pre-IPO companies through EquityZen, part of Morgan Stanley.

Get Started

GenixCure Stock

GenixCure is a biotech company developing gene therapy using AAV vectors for rare and neurodegenerative diseases and genetic medicine.

About GenixCure Stock

Founded

2019

Industries

Natural Resources, Software, Artificial Intelligence

GenixCure is a biotechnology company focused on developing advanced gene therapy solutions, particularly using adeno-associated virus (AAV) vector technology. It targets rare genetic disorders and neurodegenerative diseases by building innovative genetic medicine platforms. The company aims to translate cutting-edge biomedical research into therapeutic applications that address unmet medical needs and improve patient outcomes globally.

GenixCure Management

Leadership team at GenixCure

Founder & Chief Executive Officer

Hong Sung Moon

CFO

Yoo Seung-hwan

Locked Features

Join now and verify your accreditation status to gain access to:

  • GenixCure Current Valuation
  • GenixCure Stock Price
  • GenixCure Management
  • Available deals in GenixCure and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • GenixCure Cap Table and Funding History by Share Class and Liquidity Preferences
    • GenixCure Revenue and Financials
    • GenixCure Highlights
    • GenixCure Business Model
    • GenixCure Risk Factors
  • GenixCure Research Report from SACRA Research
Join Now

Trading GenixCure Stock

How to invest in GenixCure stock?

Accredited investors can buy pre-IPO stock in companies like GenixCure through EquityZen funds. These investments are made available by existing GenixCure shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.

How to sell GenixCure stock?

Shareholders can sell their GenixCure stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 55K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like GenixCure